PULMONARY ENTERIC ADENOCARCINOMA (PEAC) - CASE REPORT AND REVIEW OF RELEVANT DOCUMENTATION

Văn Công Cung 1,
1 National lung hospital

Main Article Content

Abstract

According to the World Health Organization 2015 classification of Thoracic tumors, updated to 2021, the adenocarcinoma group includes the following subtypes: (1) Minimally invasive adenocarcinoma (MIA); (2) Invasive non-mucinous adenocarcinoma (INMA); (3) Invasive mucinous adenocarcinoma (IMA); (4) Colloid adenocarcinoma (CA); (5) Fetal adenocarcinoma (FA); (6) Enteric-type adenocarcinoma (EA). In which, Enteric-type Adenocarcinoma (EA) or Pulmonary Enteric Adenocarcinoma (PEAC) is said to be very rare, with high malignancy, rapid progression, very difficult to treat. Diagnosis of lung adenocarcinoma is generally based on pathological findings; Subtype diagnoses require immunohistochemistry support. We present a rare case of PEAC with quite special images: large tumor in upper lobe of left lung, large lymph node masses around trachea, main and inferior bronchus of Carina; All of the above abnormalities had internal calcifications. There are also many other nodules (atypically secondary) of the ipsilateral and contralateral lung. Initially, the case was diagnosed and monitored for pulmonary tuberculosis; The definitive diagnosis of PEAC by histopathology and immunohistochemistry was obtained by transthoracic biopsy under computed tomography guidance.

Article Details

References

1. Cowan ML, Li QK, Illei PB. CDX-2 Expression in Primary Lung Adenocarcinoma. Appl Immunohistochem Mol Morphol. 2016 Jan;24(1):16-9. doi: 10.1097/ PAI.0000000000000250. PMID: 26469326
2. Qureshi A, Furrukh M. Enteric adenocarcinoma lung: a rare presentation in an Omani woman. BMJ Case Rep. 2013 Jan 25;2013:bcr2012007667. doi: 10.1136/bcr-2012-007667. PMID: 23355573
3. Zhao L, Huang S, Liu J, et al. Clinicopathological, radiographic, and oncogenic features of primary pulmonary enteric adenocarcinoma in comparison with invasive adenocarcinoma in resection specimens. Medicine (Baltimore). 2017 Sep;96(39):e8153. doi: 10.1097/MD.0000000000008153. PMID: 28953659
4. Metro G, Valtorta E, Siggillino A, et al. Enteric-type adenocarcinoma of the lung harbouring a novel KRAS Q22K mutation with concomitant KRAS polysomy: a case report. Ecancermedicalscience. 2015 Jul 28;9:559. doi: 10.3332/ecancer.2015.559. eCollection 2015. PMID: 26284123
6. Hu CH, Shi S, Dong W, et al. Hyperprogressive Disease After Immunotherapy: A Case Report of Pulmonary Enteric Adenocarcinoma. Front Oncol. 2022 Mar 7;12:799549. doi: 10.3389/ fonc.2022.799549. eCollection 2022. PMID: 35321429
7. Li H, Cao W. Pulmonary enteric adenocarcinoma: a literature review. J Thorac Dis. 2020 Jun;12(6):3217-3226. doi: 10.21037/jtd-19- 4171. PMID: 32642243
8. Chen M, Liu P, Yan F, et al. Distinctive features of immunostaining and mutational load in primary pulmonary enteric adenocarcinoma: implications for differential diagnosis and immunotherapy. J Transl Med. 2018 Mar 27;16(1):81. doi: 10.1186/s12967-018-1449-z. PMID: 29587865
9. Sun WW, Xu ZH, Wang CF, et al. Pulmonary enteric adenocarcinoma with pancreatic metastasis: A case report. Oncol Lett. 2017 Jun;13(6):4651-4656. doi: 10.3892/ol.2017.6060. Epub 2017 Apr 20. PMID: 28599465